Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Assertio Holdings, Inc.    ASRT

ASSERTIO HOLDINGS, INC.

(ASRT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
0.5999(c) 0.6148(c) 0.6741(c) 0.63(c) 0.5901(c) Last
18 974 572 14 223 416 15 647 149 8 981 392 6 372 450 Volume
+11.30% +2.48% +9.65% -6.54% -6.33% Change
More quotes
Financials (USD)
Sales 2020 107 M - -
Net income 2020 -9,04 M - -
Net cash position 2020 60,0 M - -
P/E ratio 2020 -6,56x
Yield 2020 -
Sales 2021 112 M - -
Net income 2021 -12,5 M - -
Net cash position 2021 45,0 M - -
P/E ratio 2021 -5,90x
Yield 2021 -
Capitalization 63,3 M 63,3 M -
EV / Sales 2020 0,03x
EV / Sales 2021 0,16x
Nbr of Employees 125
Free-Float 95,8%
More Financials
Company
Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Suspension, INDOCIN (indomethacin) Suppositories, OXAYDO tablets, SPRIX Nasal Spray, VIVLODEX capsules, ZIPSOR Liquid filled capsules and ZORVOLEX capsules. The Company is... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about ASSERTIO HOLDINGS, INC.
2020ASSERTIO HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020ASSERTIO : Significant Insider Selling in Shares of Assertio Holdings (ASRT) Con..
MT
2020INSIDER TRENDS : Selling By Insiders Lingers at Assertio Holdings
MT
2020ASSERTIO : Given Until June 28 to Meet $1 Minimum Bid Rule to Maintain Nasdaq Li..
MT
2020ASSERTIO HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued ..
AQ
2020Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Na..
GL
2020INSIDER TRENDS : Insider 90-Day Selling Trend Continued at Assertio Holdings
MT
2020ASSERTIO : Therapeutics Declines Amid Restructuring Plan; CEO Resignation
MT
2020ASSERTIO HOLDINGS, INC. : Costs Associated with Exit or Disposal Activities, Cha..
AQ
2020ASSERTIO : Announces Restructuring Plan and Leadership Changes
AQ
2020ASSERTIO : to Present at the Stifel 2020 Virtual Healthcare Conference on Novemb..
AQ
2020ASSERTIO : to Present at the Stifel 2020 Virtual Healthcare Conference on Novemb..
AQ
2020Assertio to Present at the Stifel 2020 Virtual Healthcare Conference on Novem..
GL
2020ASSERTIO : Reports Third Quarter 2020 Financial Results
AQ
2020ASSERTIO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
More news
News in other languages on ASSERTIO HOLDINGS, INC.

- No features available -

More news
Chart ASSERTIO HOLDINGS, INC.
Duration : Period :
Assertio Holdings, Inc. Technical Analysis Chart | ASRT | US04546C1062 | MarketScreener
Technical analysis trends ASSERTIO HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 0,75 $
Last Close Price 0,59 $
Spread / Highest target 27,1%
Spread / Average Target 27,1%
Spread / Lowest Target 27,1%
EPS Revisions
Managers and Directors
NameTitle
Daniel A. Peisert President, Chief Executive Officer & Director
Peter D. Staple Chairman
William T. McKee Director
James L. Tyree Director
Heather L. Mason Director
Sector and Competitors
1st jan.Capitalization (M$)
ASSERTIO HOLDINGS, INC.65.02%63
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993